Albion Drug Discovery Services Ltd 13959533 false 2024-03-01 2025-02-28 2025-02-28 The principal activity of the company is drug discovery and research Digita Accounts Production Advanced 6.30.9574.0 true 13959533 2024-03-01 2025-02-28 13959533 2025-02-28 13959533 core:CurrentFinancialInstruments core:WithinOneYear 2025-02-28 13959533 bus:Micro-entities 2024-03-01 2025-02-28 13959533 bus:AuditExemptWithAccountantsReport 2024-03-01 2025-02-28 13959533 bus:FullAccounts 2024-03-01 2025-02-28 13959533 bus:SmallCompaniesRegimeForAccounts 2024-03-01 2025-02-28 13959533 bus:RegisteredOffice 2024-03-01 2025-02-28 13959533 bus:Director1 2024-03-01 2025-02-28 13959533 bus:PrivateLimitedCompanyLtd 2024-03-01 2025-02-28 13959533 bus:Agent1 2024-03-01 2025-02-28 13959533 countries:AllCountries 2024-03-01 2025-02-28 13959533 2023-03-01 2024-02-29 13959533 2024-02-29 13959533 core:CurrentFinancialInstruments core:WithinOneYear 2024-02-29 iso4217:GBP xbrli:pure

Registration number: 13959533

Albion Drug Discovery Services Ltd

Annual Report and Unaudited Financial Statements

for the Year Ended 28 February 2025

 

Albion Drug Discovery Services Ltd

Contents

Company Information

1

Balance Sheet

2

Notes to the Unaudited Financial Statements

2

 

Albion Drug Discovery Services Ltd

Company Information

Director

Dr Marc Rogers

Registered office

Cart House 2
Copley Hill Business Park
Cambridge Road
Babraham
Cambridge
CB22 3GN

Accountants

Tim Phillips & Co Ltd Cart House 2
Copley Hill Business Park
Cambridge Road
Babraham
Cambridge
CB22 3GN

 

Albion Drug Discovery Services Ltd

(Registration number: 13959533)
Balance Sheet as at 28 February 2025

2025
£

2024
£

Current assets

54,009

59,210

Creditors: Amounts falling due within one year

(4,175)

(11,939)

Total assets less current liabilities

49,834

47,271

Accruals and deferred income

(1,674)

(1,300)

 

48,160

45,971

Capital and reserves

48,160

45,971

1

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 1 (2024 - 1).

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the micro entities regime and FRS 105 ‘The Financial Reporting Standard Applicable to the Micro-entities Regime.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

Approved and authorised by the director on 18 November 2025
 

.........................................
Dr Marc Rogers
Director

For the financial year ending 28 February 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.